IL23estolääkkeet
IL23estolääkkeet, also known as IL-23 inhibitors, are a class of biologic medications used to treat certain autoimmune diseases. These drugs work by targeting interleukin-23 (IL-23), a protein that plays a significant role in the inflammatory processes associated with these conditions. IL-23 is a cytokine that promotes the development and survival of specific immune cells, such as T helper 17 (Th17) cells, which contribute to chronic inflammation. By blocking the action of IL-23, these medications help to reduce inflammation and alleviate the symptoms of the diseases they treat.
Currently, IL23estolääkkeet are approved for the treatment of several chronic inflammatory conditions, including plaque psoriasis, psoriatic
The administration of IL23estolääkkeet is typically done through subcutaneous injection or intravenous infusion, depending on the